Here you’ll find our latest quarterly results, corporate reports, economic statement and By the Numbers report builder. You can also access reports from previous years.

Results alert

Receive an alert when we release our quarterly and annual results.

Sign up

Q3 2023 results

Return to work at 100% pre-injury earnings within 12 months*

Return to work at 100% pre-injury earnings within 12 months*

In Q3, 87% of people with workplace injuries or illnesses returned to work with no wage loss within 12 months, excluding those with COVID-19 claims.

Service timeliness 96% Decisions made within 10 business days 78% Claims paid within 15 days

Service timeliness

Eligibility decision timeliness on lost-time claims continued to meet our 2023 target of 96% in Q3. Payment timeliness continued to exceed our 2023 target at 78%.

Registered claim volume* (excluding COVID-19) 7% higher than Q3 2022

Registered claim volume*

There were seven per cent more Schedule 1 claims registered in Q3 2023 (49,468) than in Q3 2022 (46,270), when excluding COVID-19 claims.

Appeals total allowance rate 29%

Appeals total allowance rate

The percentage of appeal issues that were allowed or allowed in part remained within the expected range of 26 to 33 per cent.

Average composite duration in days* 62.9 Days (excluding COVID-19 claims)

Average composite duration in days*

Durations measure the time that claims continue to require benefits. They continued to improve in Q3 – average composite duration decreased by 0.6 days compared to last quarter.

Sufficiency Ratio 118.0%

Sufficiency Ratio

The Sufficiency Ratio** held steady in Q3 compared to Q2.

Net assets $6 billion in reserve

Net assets

Please update to read: Our net assets on a sufficiency ratio basis remained steady in Q3 compared to Q2.

*Schedule 1 only

**Sufficiency Ratio reporting is not significantly impacted by IFRS 17, the new insurance accounting standard which came into effect on January 1, 2023


See a glossary of terms used in our reporting.

Past results

Please contact us at for all quarterly results from Q1 2022 onwards or if you have questions about our corporate reporting.

Learn about the WSIB Board of Directors